Search

Your search keyword '"Hertervig, Erik"' showing total 14 results

Search Constraints

Start Over You searched for: Author "Hertervig, Erik" Remove constraint Author: "Hertervig, Erik" Publisher elsevier bv Remove constraint Publisher: elsevier bv
14 results on '"Hertervig, Erik"'

Search Results

1. Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial

2. 887: WITHDRAWAL OF INFLIXIMAB OR ANTI-METABOLITE THERAPY IN CROHN'S DISEASE PATIENTS IN SUSTAINED REMISSION ON COMBINATION THERAPY: A RANDOMIZED UNBLINDED CONTROLLED TRIAL (SPARE)

3. Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial

4. Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease

5. Su1912 CDEIS SCORE OF 2 IS OPTIMAL CUT-OFF ASSOCIATED WITH LOWER RISK OF DISEASE PROGRESSION IN EARLY CROHN'S DISEASE: DATA FROM THE CALM STUDY

6. Mo1886 REAL-WORLD EFFECTIVENESS OF VEDOLIZUMAB IN CROHN'S DISEASE: WEEK 52 RESULTS FROM THE SWEDISH MULTI-CENTER, PROSPECTIVE, OBSERVATIONAL SVEAH CD STUDY

7. Sa1812 – Endoscopic and Deep Remission At 1 Year Prevents Disease Progression in Early Crohn's Disease: Long-Term Data from Calm

8. Mo1894 - Clinical Effectiveness of Vedolizumab: Interim Analysis of the Swedish Observational Study on Vedolizumab Assessing Effectiveness and Healthcare Resource Utilization in Patients with Ulcerative Colitis (Sveah UC)

9. Mo1892 - Clinical Effectiveness of Vedolizumab: Interim Analysis of the Swedish Observational Study on Vedolizumab Assessing Effectiveness and Healthcare Resource Utilization in Patients with Crohn's Disease (Sveah CD)

10. Tu1368 Vedolizumab in Inflammatory Bowel Disease, the First Experience From the Swedish IBD Registry (SWIBREG)

11. Mo1209 Clinical Remisison and Quality of Life in Collagenous Colitis: A One-Year, Randomised, Placebo-Controlled Study With Low-Dose Budesonide (BUC-63/ COC)

12. Infliximab as Rescue Therapy in Steroid-Refractory Acute Ulcerative Colitis; A Retrospective Follow-up Study

14. Infliximab as Rescue Therapy in Severe to Moderately Severe Ulcerative Colitis: A Randomized, Placebo-Controlled Study

Catalog

Books, media, physical & digital resources